National and Kapodistrian University of Athens
Η επίδραση της από του στόματος και της μακράς δράσης ενέσιμης αντιψυχωτικής αγωγής στη σεξουαλική δραστηριότητα και σεξουαλική ικανοποίηση ασθενών με σχιζοφρένεια και με διπολική διαταραχή
Abstract
dc:descriptionIntroduction: Patients with psychosis can develop sexual dysfunction, which may be related to the disease itself, psychosocial factors, comorbid somatic health, and the use of psychotropic medication. Aim: Investigating the type and frequency of sexual dysfunction in patients diagnosed with schizophrenia or bipolar disorder in order to clarify the side effects of antipsychotics in sexual function. Methods: This is a multicenter, cross-sectional study, involving patients diagnosed with schizophrenia (79.3%) or bipolar disorder (20.7%) who treated in the Department of Psychiatry and Community Mental Health Centers from November 2018 to December 2019. Patients were enrolled in the study after signed informed consent. Demographic and clinical data were collected from patients through a semi-structured interview. The Antipsychotics and Sexual Functioning Questionnaire (ASFQ) was used to assess sexual function. Data were analyzed with IBM SPSS 21.0 (Statistical Package for Social Sciences) and the level of statistical significance was set 0.05. Results: A total of 87 outpatients who were treated with antipsychotics were recruited in the study. The mean age was 43.6 years (SD 10.4), with a range of 19 to 65 years, while the mean duration of the disease was 16.9 years (SD 8.9). Overall, only 9.1% of patients spontaneously reported sexual dysfunction. Specifically, 52.6% of patients had decreased sexual desire and 46.6% experienced orgasm dysfunction. 10.5% of patients had galactorrhoea and 17.1% reported gynecomastia. In men, 37.2% had decreased erection, while 56.2% had decreased ejaculation. In women, 48.3% experienced decreased vaginal lubrication and 40% had no menstruation during the last four to six weeks. Patients treated with oral first-generation antipsychotics had more difficulty in achieving orgasm (p=0.05) and decreased erection capacity (p=0.016). In contrast, patients treated with oral second-generation antipsychotics had decreased ejaculation capacity (p=0.017). Patients on combination therapy were associated with higher rates of sexual anhedonia (p=0.019). A positive correlation between the number of antipsychotics' side effects and the sexual anhedonia (p<0.001), and specifically the decreased ejaculation (p=0.006), was found. The association between sexual dysfunction and the different variables analyzed using multivariant linear regression, shows that age, occupation, and educational status, correlate significantly to sexual dysfunction. Conclusions: Sexual dysfunction is one of the side effects of antipsychotic treatment, which could have a significant impact on patients' adherence to prescription antipsychotic drugs and quality of life.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Angelaki, Maria
- Αγγελάκη, Μαρία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/49141